Patent · US Active

Neutral nanotransporters

US10138485B2 · kind B2 · utility

19Cited by

232References

15Claims

0Family size

Assignee

RXi Pharmaceuticals Corporation · US

Inventors

Anastasia Khvorova · Boulder, US
William Salomon · Worcester, US
Joanne Kamens · Newton, US
Dmitry Samarsky · Berlin, DE
Tod M. Woolf · Sudbury, US
Michelle Miller · East Walpole, US
Karen G. Bulock · Mendon, US

Key dates

Filing date	Sep 22, 2009
Grant date	Nov 27, 2018
Priority date	—
Expiry date	Aug 21, 2032

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC12N2320/53
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

Neutral lipid formulations for nucleic acid delivery are provided according to the invention. The neutral lipid formulations include hydrophobically modified polynucleotides and fat mixtures. Methods of using the neutral lipid formulations are also provided.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.